Vanessa Carle - Aug 29, 2022 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
Secretary
Signature
/Vanessa Carle/
Stock symbol
LEXX
Transactions as of
Aug 29, 2022
Transactions value $
$0
Form type
4
Date filed
8/29/2022, 05:32 PM
Previous filing
Sep 2, 2021
Next filing
Nov 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LEXX common shares 67 Aug 29, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LEXX Stock Options Award $0 +12.5K +45.34% $0.00 40.1K Aug 29, 2022 Common Shares 12.5K $2.91 Direct
holding LEXX Warrants 67 Aug 29, 2022 Common Shares 67 $36.00 Direct
holding LEXX Stock Options 12.6K Aug 29, 2022 Common Shares 12.5K $5.31 Direct
holding LEXX Stock Options 17.6K Aug 29, 2022 Common Shares 5K $7.08 Direct
holding LEXX Stock Options 27.6K Aug 29, 2022 Common Shares 10K $6.23 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.